As of 2026-09-25, the Relative Valuation of Kezar Life Sciences Inc (KZR) is (131.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.29 USD, the upside of Kezar Life Sciences Inc based on Relative Valuation is -1909.8%.
The range of the Relative Valuation is (85.22) - (164.54) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 23.0x | 19.1x |
| Forward P/E multiples | 9.9x - 21.7x | 15.7x |
| Fair Price | (85.22) - (164.54) | (131.93) |
| Upside | -1269.1% - -2357.0% | -1909.8% |
| Date | P/E |